Acinetobacter Peritoneal Dialysis Peritonitis: Description and Relation to the spice Family of Organisms

O. Friedman,S. Jassal,J. Bargman

DOI: https://doi.org/10.1177/089686080802800217

2008-03-01

Peritoneal Dialysis International

Abstract:A 57-year-old patient with end-stage renal disease due to AA amyloidosis developed his first episode of peritonitis 14 months after initiation of continuous ambulatory peritoneal dialysis (CAPD). It was determined to be due to Acinetobacter calcoaceticus-baumannii complex. The isolate’s antibiogram as reported by the microbiology laboratory read as follows: resistant to ampicillin, cefazolin; sensitive to ciprofloxacin, gentamicin, tobramycin, ceftriaxone, ceftazidime, septra, piperacillin/tazobactam. He was subsequently maintained on intraperitoneal (IP) ceftazidime, to which the organism as demonstrated was susceptible in vitro. Although his peritoneal effluent initially cleared, it became cloudy 10 days into his antibiotic course, yet was culture negative. His antimicrobial regimen was then switched to IP tobramycin and oral ciprofloxacin, to which he responded. Despite refinements in preventive and management strategies, peritonitis continues to represent a leading impediment to the performance of peritoneal dialysis (PD). Antibiotic resistance stands among the causes of relapsing, repeat, and refractory peritonitis. We hypothesize that the aforementioned case may well illustrate this principle, despite the negative repeat culture, as Acinetobacter species and several other unique gramnegative bacteria are capable of producing betalactamases when subjected to an inducing beta-lactam antibiotic. In this sense, the purpose of our paper is both to highlight this property and to review the literature as it relates to other groups’ experiences with Acinetobacter PD peritonitis.